Zobrazeno 1 - 5
of 5
pro vyhledávání: '"D R Wada"'
Autor:
D R Wada, Timothy J. Carrothers, Daniel E. Salazar, J Shi, Shashank Rohatagi, SaeHeum Song, Reinilde Heyrman
Publikováno v:
Clinical Pharmacology & Therapeutics. 91:250-256
Modeling and simulation were used extensively in the development of an indication for the use of olmesartan medoxomil in pediatric patients with hypertension. Simulations based on models developed in adult patients indicated that two dose groups were
Publikováno v:
Clinical pharmacology and therapeutics. 90(6)
High development cost, low development success, cost-disciplined health-care policies, and intense competition demand an efficient drug development process. New compounds need to bring value to patients by being safe, efficacious, and cost-effective
Autor:
J W, Mandema, D R, Wada
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 275(3)
This investigation was carried out to characterize the rate and extent of acute tolerance development to the pharmacodynamics of alfentanil in the rat with the electroencephalogram (EEG) as a measure of alfentanil's effects on the central nervous sys
Publikováno v:
Anesthesia and analgesia. 77(6)
Flumazenil, a benzodiazepine antagonist, clearly reverses midazolam-induced sedation; reversal of ventilatory depression has not been as well demonstrated. Thirty-two subjects completed this randomized, double-blind, placebo-controlled study investig
Publikováno v:
Anesthesia & Analgesia. 77:1207
Flumazenil, a benzodiazepine antagonist, clearly reverses midazolam-induced sedation; reversal of ventilatory depression has not been as well demonstrated. Thirty-two subjects completed this randomized, double-blind, placebo-controlled study investig